keyword
https://read.qxmd.com/read/38493212/tumor-infiltrating-immune-cells-and-survival-in-head-and-neck-squamous-cell-carcinoma-a-retrospective-computational-study
#1
JOURNAL ARTICLE
Lei Zhang, Wei-Quan Wang, Jun-Hong Chen, Jia Feng, Ya-Zhou Liao, You Zou, Rong Liu
The immune infiltration profiles of the tumor microenvironment have effects on the prognosis of head and neck squamous cell carcinoma (HNSCC). Whereas, HNSCC is a heterogeneous group of tumors, but past work has not taken this into consideration. Herein, we investigate the associations between survival and the function of immune cells in different tumorigenic sites of HNSCC. 1149 samples of HNSCC were collected from publicly accessible databases. Based on gene expression data, CIBERSORTx was applied to determine the proportion of 22 immune cell subpopulations...
March 16, 2024: Scientific Reports
https://read.qxmd.com/read/38443768/toxoplasma-gondii-ist-suppresses-inflammatory-and-apoptotic-responses-by-inhibiting-stat1-mediated-signaling-in-ifn-%C3%AE-tnf-%C3%AE-stimulated-hepatocytes
#2
JOURNAL ARTICLE
Seung-Hwan Seo, Ji-Eun Lee, Do-Won Ham, Eun-Hee Shin
The dense granule protein of Toxoplasma gondii, inhibitor of signal transducer and activator of transcription 1 (IST) is an inhibitor of signal transducer and activator of transcription 1 (STAT1) transcriptional activity that binds to STAT1 and regulates the expression of inflammatory molecules in host cells. A sterile inflammatory liver injury in pathological acute liver failures occurs when excessive innate immune function, such as the massive release of IFN-γ and TNF-α, is activated without infection...
February 2024: Parasites Hosts Dis
https://read.qxmd.com/read/38441205/a-large-single-center-cohort-of-bare-lymphocyte-syndrome-immunological-and-genetic-features-in-turkey
#3
JOURNAL ARTICLE
Hilal Ünsal, Canan Caka, Hacer Neslihan Bildik, Saliha Esenboğa, Alphan Kupesiz, Barış Kuşkonmaz, Duygu Uçkan Cetinkaya, Mirjam van der Burg, İlhan Tezcan, Deniz Çağdaş
Major histocompatibility complex class II (MHC-II) deficiency or bare lymphocyte syndrome (BLS) is a rare, early-onset, autosomal recessive, and life-threatening inborn error of immunity. We aimed to assess the demographic, clinical, laboratory, follow-up, and treatment characteristics of patients with MHC-II deficiency, together with their survival. We retrospectively investigated 21 patients with MHC-II deficiency. Female/male ratio was 1.63. The median age at diagnosis was 16.3 months (5 months-9...
January 2024: Scandinavian Journal of Immunology
https://read.qxmd.com/read/38405853/kdm6a-regulates-immune-response-genes-in-multiple-myeloma
#4
Daphne Dupéré-Richer, Alberto Riva, Sayantan Maji, Benjamin G Barwick, Heidi Casellas Román, Amin Sobh, Gabrielle Quickstad, Jianping Li, Umasankar De, Crissandra Piper, Marta Kulis, Teresa Ezponda, José Ignacio Martin-Subero, Giovanni Tonon, Weizhou Zhang, Constantine S Mitsiades, Lawrence H Boise, Richard L Bennett, Jonathan D Licht
UNLABELLED: The histone H3K27 demethylase KDM6A is a tumor suppressor in multiple cancers, including multiple myeloma (MM). We created isogenic MM cells disrupted for KDM6A and tagged the endogenous protein to facilitate genome wide studies. KDM6A binds genes associated with immune recognition and cytokine signaling. Most importantly, KDM6A binds and activates NLRC5 and CIITA encoding regulators of Major Histocompatibility Complex (MHC) genes. Patient data indicate that NLRC5 and CIITA, are downregulated in MM with low KDM6A expression...
February 12, 2024: bioRxiv
https://read.qxmd.com/read/38360922/compact-zinc-finger-architecture-utilizing-toxin-derived-cytidine-deaminases-for-highly-efficient-base-editing-in-human-cells
#5
JOURNAL ARTICLE
Friedrich Fauser, Bhakti N Kadam, Sebastian Arangundy-Franklin, Jessica E Davis, Vishvesha Vaidya, Nicola J Schmidt, Garrett Lew, Danny F Xia, Rakshaa Mureli, Colman Ng, Yuanyue Zhou, Nicholas A Scarlott, Jason Eshleman, Yuri R Bendaña, David A Shivak, Andreas Reik, Patrick Li, Gregory D Davis, Jeffrey C Miller
Nucleobase editors represent an emerging technology that enables precise single-base edits to the genomes of eukaryotic cells. Most nucleobase editors use deaminase domains that act upon single-stranded DNA and require RNA-guided proteins such as Cas9 to unwind the DNA prior to editing. However, the most recent class of base editors utilizes a deaminase domain, DddAtox , that can act upon double-stranded DNA. Here, we target DddAtox fragments and a FokI-based nickase to the human CIITA gene by fusing these domains to arrays of engineered zinc fingers (ZFs)...
February 15, 2024: Nature Communications
https://read.qxmd.com/read/38335966/hypoimmune-islets-achieve-insulin-independence-after-allogeneic-transplantation-in-a-fully-immunocompetent-non-human-primate
#6
JOURNAL ARTICLE
Xiaomeng Hu, Kathy White, Chi Young, Ari G Olroyd, Paul Kievit, Andrew J Connolly, Tobias Deuse, Sonja Schrepfer
Allogeneic transplantation of pancreatic islets for patients with difficult-to-control diabetes mellitus is severely hampered by the requirement for continuous immunosuppression and its associated morbidity. We report that allogeneic transplantation of genetically engineered (B2M-/- , CIITA-/- , CD47+ ), primary, hypoimmune, pseudo-islets (p-islets) results in their engraftment into a fully immunocompetent, diabetic non-human primate wherein they provide stable endocrine function and enable insulin independence without inducing any detectable immune response in the absence of immunosuppression...
February 8, 2024: Cell Stem Cell
https://read.qxmd.com/read/38315170/polycomb-repressor-complex-2-suppresses-interferon-responsive-mhc-ii-expression-in-melanoma-cells-and-is-associated-with-anti-pd-1-resistance
#7
JOURNAL ARTICLE
Jamaal L James, Brandie C Taylor, Margaret L Axelrod, Xiaopeng Sun, Lindsey N Guerin, Paula I Gonzalez-Ericsson, Yu Wang, Violeta Sanchez, Catherine C Fahey, Melinda E Sanders, Yaomin Xu, Emily Hodges, Douglas B Johnson, Justin M Balko
BACKGROUND: Despite the remarkable success of immunotherapy in treating melanoma, understanding of the underlying mechanisms of resistance remains limited. Emerging evidence suggests that upregulation of tumor-specific major histocompatibility complex-II (tsMHC-II) serves as a predictive marker for the response to anti-programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1) therapy in various cancer types. The genetic and epigenetic pathways modulating tsMHC-II expression remain incompletely characterized...
November 20, 2023: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38310908/host-transcriptomics-and-machine-learning-for-secondary-bacterial-infections-in-patients-with-covid-19-a-prospective-observational-cohort-study
#8
JOURNAL ARTICLE
Meagan Carney, Tiana Maria Pelaia, Tracy Chew, Sally Teoh, Amy Phu, Karan Kim, Ya Wang, Jonathan Iredell, Yoann Zerbib, Anthony McLean, Klaus Schughart, Benjamin Tang, Maryam Shojaei, Kirsty R Short
BACKGROUND: Viral respiratory tract infections are frequently complicated by secondary bacterial infections. This study aimed to use machine learning to predict the risk of bacterial superinfection in SARS-CoV-2-positive individuals. METHODS: In this prospective, multicentre, observational cohort study done in nine centres in six countries (Australia, Indonesia, Singapore, Italy, Czechia, and France) blood samples and RNA sequencing were used to develop a robust model of predicting secondary bacterial infections in the respiratory tract of patients with COVID-19...
January 30, 2024: The Lancet. Microbe
https://read.qxmd.com/read/38310446/deciphering-immune-related-gene-signatures-in-diabetic-retinopathy-insights-from-in-silico-analysis-and-in-vitro-experiment
#9
JOURNAL ARTICLE
Nan Xia, Qingsong Zhao, Jinmei Xu, Zhifeng Cheng
BACKGROUND: Diabetes retinopathy (DR) is one of the most common microvascular consequences of diabetes, and the economic burden is increasing. Our aim is to decipher the relevant mechanisms of immune-related gene features in DR and explore biomarkers targeting DR. Provide a basis for the treatment and prevention of DR. METHOD: The immune infiltration enrichment score of DR patients was evaluated from the single- cell RNA sequencing dataset, and the samples were divided into low immune subgroups and high immune subgroups based on this result...
January 17, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38225288/generation-and-optimization-of-off-the-shelf-immunotherapeutics-targeting-tcr-v%C3%AE-2-t-cell-malignancy
#10
JOURNAL ARTICLE
Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine Foss, Michael Girardi
Current treatments for T cell malignancies encounter issues of disease relapse and off-target toxicity. Using T cell receptor (TCR)Vβ2 as a model, here we demonstrate the rapid generation of an off-the-shelf allogeneic chimeric antigen receptor (CAR)-T platform targeting the clone-specific TCR Vβ chain for malignant T cell killing while limiting normal cell destruction. Healthy donor T cells undergo CRISPR-induced TRAC, B2M and CIITA knockout to eliminate T cell-dependent graft-versus-host and host-versus-graft reactivity...
January 15, 2024: Nature Communications
https://read.qxmd.com/read/38215755/engineering-human-pluripotent-stem-cell-lines-to-evade-xenogeneic-transplantation-barriers
#11
JOURNAL ARTICLE
Hannah A Pizzato, Paula Alonso-Guallart, James Woods, Jon P Connelly, Todd A Fehniger, John P Atkinson, Shondra M Pruett-Miller, Frederick J Monsma, Deepta Bhattacharya
Successful allogeneic human pluripotent stem cell (hPSC)-derived therapies must overcome immunological rejection by the recipient. To build reagents to define these barriers, we genetically ablated β2M, TAP1, CIITA, CD74, MICA, and MICB to limit expression of HLA-I, HLA-II, and natural killer (NK) cell activating ligands in hPSCs. Transplantation of these cells that also expressed covalent single chain trimers of Qa1 and H2-Kb to inhibit NK cells and CD55, Crry, and CD59 to inhibit complement deposition led to persistent teratomas in wild-type mice...
December 22, 2023: Stem Cell Reports
https://read.qxmd.com/read/38214420/nlrp3-regulates-ciita-mhc-ii-axis-and-interferon-%C3%AE-inducible-chemokines-in-malassezia-globosa-infected-keratinocytes
#12
JOURNAL ARTICLE
Yun Luo, Jin-Feng Tang, Fei-Fei Gao, Juan-Hua Quan, Chuan-Ting Ma, Shi-Jie Li, Yi-Ming Fan
CIITA, a member of NOD-like receptor (NLR) family, is the major MHC II trans-activator and mediator of Th1 immunity, but its function and interaction with NLRP3 have been little studied. We found activation of NLRP3 inflammasome, increased expression of CIITA, CBP, pSTAT1, STAT1, MHC II, IFN-γ and IFN-γ-inducible chemokines (CCL1 and CXCL8), and colocalisation of NLRP3 with CIITA in Malassezia folliculitis lesions, Malassezia globosa-infected HaCaT cells and mouse skin. CoIP with anti-CIITA or anti-NLRP3 antibody pulled down NLRP3 or both CIITA and ASC...
January 2024: Mycoses
https://read.qxmd.com/read/38201622/limited-effects-of-class-ii-transactivator-based-immunotherapy-in-murine-and-human-glioblastoma
#13
JOURNAL ARTICLE
A Katherine Tan, Aurelie Henry, Nicolas Goffart, Sofie van Logtestijn, Vincent Bours, Elly M Hol, Pierre A Robe
BACKGROUND: The major histocompatibility complex type II is downregulated in glioblastoma (GB) due to the silencing of the major transcriptional regulator class II transactivator (CIITA). We investigated the pro-immunogenic potential of CIITA overexpression in mouse and human GB. METHODS: The intracerebral growth of wildtype GL261-WT cells was assessed following contralateral injection of GL261-CIITA cells or flank injections with GL261-WT or GL261-CIITA cells. Splenocytes obtained from mice implanted intracerebrally with GL261-WT, GL261-CIITA cells or phosphate buffered saline (PBS) were transferred to other mice and subsequently implanted intracerebrally with GL261-WT...
December 30, 2023: Cancers
https://read.qxmd.com/read/38195462/expression-of-hla-dr-by-mesenchymal-stromal-cells-in-the-platelet-lysate-era-an-obsolete-release-criterion-for-mscs
#14
JOURNAL ARTICLE
Zyrafete Kuçi, Natascha Piede, Kathrin Vogelsang, Lisa-Marie Pfeffermann, Sibylle Wehner, Emilia Salzmann-Manrique, Miriam Stais, Hermann Kreyenberg, Halvard Bonig, Peter Bader, Selim Kuçi
BACKGROUND: According to the definition of the International Society for Cell and Gene Therapy (ISCT), mesenchymal stromal cells (MSCs) do not express HLA-DR. This phenotypic marker as a release criterion for clinical use was established at a time when MSCs were expanded in fetal bovine serum (FBS)-containing media. Replacement of FBS with platelet lysate (PLs) as a medium supplement induced a significantly higher fraction of MSCs to express MHC class II antigens. METHODS: As this raised concerns that such MSCs may play the role of antigen-presenting cells for T cells, in the current study, we studied major factors that may induce HLA-DR on MSCs by means of flow cytometry and real-time polymerase chain reaction...
January 9, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38188600/comparing-the-benefits-and-drawbacks-of-stem-cell-therapy-based-on-the-cell-origin-or-manipulation-process-addressing-immunogenicity
#15
REVIEW
Sung-Ho Chang, Chung Gyu Park
Mesenchymal stem cells (MSCs) are effective in treating autoimmune diseases and managing various conditions, such as engraftment of allogeneic islets. Additionally, autologous and HLA-matched allogeneic MSCs can aid in the engraftment of human allogeneic kidneys with or without low doses of tacrolimus, respectively. However, HLA alloantigens are problematic because cell therapy uses more HLA-mismatched allogeneic cells than autologous for convenience and standardization. In particular, HLA-mismatched MSCs showed increased Ag-specific T/B cells and reduced viability faster than HLA-matched MSCs...
December 2023: Immune Network
https://read.qxmd.com/read/38168631/lncrna-hoxc-as2-regulates-tumor-associated-macrophage-polarization-through-the-stat1-socs1-and-stat1-ciita-pathways-to-promote-the-progression-of-non-small-cell-lung-cancer
#16
JOURNAL ARTICLE
Cunli Yin, Jing Li, Siru Li, Xi Yang, Yingchun Lu, Chunyu Wang, Bin Liu
Tumor-associated macrophages (TAMs) mainly exhibit the characteristics of M2-type macrophages, and the regulation of TAM polarization is a new target for cancer therapy, among which lncRNAs are key regulatory molecules. This study aimed to explore the effects of lncRNA-HOXC-AS2 on non-small cell lung cancer (NSCLC) by regulating TAM polarization. THP-1 cells were used to differentiate into macrophages, and TAMs were obtained by coculture with A549 cells. The M1/M2 cell phenotype and HOXC-AS2 expression were detected, and A549-derived exosomes (A549-exo) were used to elucidate the effects of A549 on macrophage polarization and HOXC-AS2 expression...
December 31, 2023: Cellular Signalling
https://read.qxmd.com/read/38145160/validation-of-a-proteomic-based-prognostic-model-for-breast-cancer-and-immunological-analysis
#17
JOURNAL ARTICLE
Yunlin Yu, Linhuan Dong, Changjun Dong, Xianlin Zhang
Breast cancer (BC) has emerged as an extremely destructive malignancy, causing significant harm to female patients and society at large. Proteomic research holds great promise for early diagnosis and treatment of diseases, and the integration of proteomics with genomics can offer valuable assistance in the early diagnosis, treatment, and improved prognosis of BC patients. In this study, we downloaded breast cancer protein expression data from The Cancer Genome Atlas (TCGA) and combined proteomics with genomics to construct a proteomic-based prognostic model for BC...
2023: International Journal of Genomics
https://read.qxmd.com/read/38115045/differential-expression-of-the-inflammatory-ciita-gene-may-be-accompanied-by-altered-bone-properties-in-intact-sex-steroid-deficient-female-rats
#18
JOURNAL ARTICLE
Vivi Fh Jensen, Maria Swanberg, Maria Herlin, Fiona E McGuigan, Niklas R Jørgensen, Kristina E Akesson
OBJECTIVE: The class II transactivator (CIITA), encoded by the CIITA gene, controls expression of immune response regulators, which affect bone homeostasis. Previously, we investigated a functional CIITA polymorphism in elderly women. Women carrying the allele associated with lower CIITA levels displayed higher bone mineral density (BMD), but also higher bone loss. The present exploratory study in a rat model sought to investigate effects of differential expression of Ciita on bone structural integrity and strength...
December 19, 2023: BMC Research Notes
https://read.qxmd.com/read/38083905/identification-of-ap002498-1-and-linc01871-as-prognostic-biomarkers-and-therapeutic-targets-for-distant-metastasis-of-colorectal-adenocarcinoma
#19
JOURNAL ARTICLE
Na Wu, Jingyi Chen, Tingru Lin, Zhaohui Zhong, Mei Li, Yimeng Yu, Jingzhu Guo, Weidong Yu
BACKGROUND: Increasing evidence suggests that lncRNA (Long non-coding RNA, lncRNA)-mediated ceRNA (competing endogenous RNA, ceRNA) networks are involved in the occurrence and progression of colorectal cancer (CRC). However, the roles of the lncRNA-miRNA-mRNA ceRNA network in distant metastasis of CRC are still unclear. METHODS: In this study, we constructed a specific ceRNA network to identify potential biomarkers and therapeutic targets for distant metastasis of CRC...
December 11, 2023: Cancer Medicine
https://read.qxmd.com/read/38073129/the-intrinsically-disordered-transcriptional-activation-domain-of-ciita-is-functionally-tuneable-by-single-substitutions-an-exception-or-a-new-paradigm
#20
JOURNAL ARTICLE
Shwetha Sreenivasan, Paul Heffren, Kyung-Shin Suh, Mykola V Rodnin, Edina Kosa, Aron W Fenton, Alexey S Ladokhin, Paul E Smith, Joseph D Fontes, Liskin Swint-Kruse
During protein evolution, some amino acid substitutions modulate protein function ("tuneability"). In most proteins, the tuneable range is wide and can be sampled by a set of protein variants that each contains multiple amino acid substitutions. In other proteins, the full tuneable range can be accessed by a set of variants that each contains a single substitution. Indeed, in some globular proteins, the full tuneable range can be accessed by the set of site-saturating substitutions at an individual "rheostat" position...
December 10, 2023: Protein Science
keyword
keyword
82955
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.